Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin detemir morning vs evening vs NPH evening as add-on to oral antidiabetic drugs in type 2 diabetes
2004-001461-18Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Mar 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of insulin detemir in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Novo Nordisk. Started Mar 2005; status: completed.
02
Drugs
insulin detemir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2004-001461-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-001461-18.